I. COMMENCED TRADING IN MAY | ||||||||
Company (Symbol) |
Date Filed |
Date Comm. |
Shares/Units (M) |
Price |
Shares Out (M) |
Lead, Other Underwriters |
Gross ($M) |
Net ($M) |
| ||||||||
| ||||||||
AltaRex Corp. (TSE:AXO) |
4/27 |
5/7 |
28.5S |
C$0.50 |
45.0 |
First Marathon Securities Ltd.; HSBC James Capel Canada Inc. |
C$19.6 (US$13.3)* |
C$18.62E |
SYNSORB Biotech Inc. (SYBB; TSE:SYB) |
3/23 |
5/13 |
9S |
$1.75 |
29.9 |
TD Securities Inc.; HSBC James Capel Canada Inc.; Loewen, Ondaatje, McCutcheon Ltd.; Canaccord Capital Corp. |
C$15.75 (US$10.7)* |
C$15E |
Trimeris Inc. (TRMS) |
4/21 |
5/27 |
2.5S |
$11.75 |
13.2 |
ING Baring Furman Selz LLC; BancBoston Robertson Stephens Inc.; SG Cowen Securities Corp. |
$29.4 |
$27.2 |
TOTAL: $58.4 II. FILED AND PENDING | ||||||||
Company (Symbol) |
Date Filed |
Shares/Units (M) |
Price Range |
Shares Out (M) |
Lead, Other UWs |
Value (M) |
||
INITIAL OFFERINGS | ||||||||
BioMarin Pharmaceutical Inc.1 (Proposed NASDAQ symbol:BMRN) |
5/4 |
N/A |
N/A |
N/A |
U.S. Bancorp Piper Jaffray; Vontobel Securities Ltd.; Schroders Securities Co. Ltd.; Leerink Swann & Company |
N/A |
||
Biopure Corp.2 (Proposed NASDAQ symbol: BPUR) |
5/19 |
N/A |
N/A |
N/A |
J.P. Morgan & Co.; Adams, Harkness & Hill Inc.; Robert W. Baird & Co. |
N/A |
||
VaxGen Inc.3 (Proposed NASDAQ symbol: VXGN) |
5/7 |
3.1S |
$13-15 |
10.8 |
Prudential Securities; Punk, Ziegel & Co. |
$40.3 |
||
1 BioMarin's registration statement leaves blank information on the number of shares to be offered, number outstanding following the offering and price per share. The offering is international the company has applied for listings on both the Nasdaq National Market and the Swiss Exchange. The maximum aggregate price, for the purpose of determining SEC fees, is $58.5 million. FOLLOW-ON OFFERINGS | ||||||||
Company (Symbol) |
Date Filed |
Shares/Units (M) |
Price Range |
Shares Out (M) |
Lead, Other UWs |
Value (M) |
||
Alliance Pharmaceutical Corp.1 (ALLP) |
4/15 |
12S |
2.72 |
33.2 |
Cruttendon Roth |
$32.6 |
||
Ribozyme Pharmaceuticals Inc. (RZYM) |
3/26 |
1.8 |
$5.50 |
11 |
|
$9.9 |
||
III. WITHDRAWN OR POSTPONEDNo offerings were withdrawn or postponed in May. Note |